Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| PYXS | NASDAQ | Pyxis Oncology, Inc. | $2.61 | -2.61% | 855K | $165.36M |
| ORMP | NASDAQ | Oramed Pharmaceuticals Inc. | $4.10 | +1.74% | 134K | $164.93M |
| ALEC | NASDAQ | Alector, Inc. | $1.48 | -0.67% | 325K | $164.32M |
| APYX | NASDAQ | Apyx Medical Corporation | $4.34 | -1.92% | 52K | $164.3M |
| LFCR | NASDAQ | Lifecore Biomedical, Inc. | $4.86 | +5.42% | 107K | $162.42M |
| NKTX | NASDAQ | Nkarta, Inc. | $2.65 | -5.02% | 699K | $162.41M |
| LFMDP | NASDAQ | LifeMD, Inc. | $23.21 | -0.31% | 565 | $160.56M |
| TLSI | NASDAQ | TriSalus Life Sciences, Inc. | $4.24 | -2.30% | 190K | $159.98M |
| YDES | NASDAQ | YD Bio Limited Ordinary Shares | $2.12 | -1.40% | 83K | $158.66M |
| TNXP | NASDAQ | Tonix Pharmaceuticals Holding Corp. | $11.85 | +2.07% | 715K | $157.5M |
| ARCT | NASDAQ | Arcturus Therapeutics Holdings Inc. | $5.53 | -4.49% | 432K | $157.18M |
| IMRX | NASDAQ | Immuneering Corporation | $4.32 | -1.59% | 465K | $156.83M |
| CRBU | NASDAQ | Caribou Biosciences, Inc. | $1.65 | -0.60% | 947K | $155.71M |
| ABOS | NASDAQ | Acumen Pharmaceuticals, Inc. | $2.20 | -1.57% | 226K | $153.84M |
| HCAT | NASDAQ | Health Catalyst, Inc. | $2.16 | -4.00% | 424K | $153.7M |
| IMDX | NASDAQ | Insight Molecular Diagnostics Inc. | $4.73 | +5.94% | 65K | $153.05M |
| QSI | NASDAQ | Quantum-Si incorporated | $0.87 | -0.36% | 2.6M | $152.34M |
| FBIOP | NASDAQ | Fortress Biotech, Inc. | $18.70 | +0.75% | 12K | $148.71M |
| SRZN | NASDAQ | Surrozen, Inc. | $19.73 | -6.76% | 184K | $147.53M |
| MOLN | NASDAQ | Molecular Partners AG | $3.89 | -2.02% | 1K | $145.92M |
| UNCY | NASDAQ | Unicycive Therapeutics, Inc. | $5.40 | -1.10% | 498K | $144.18M |
| AARD | NASDAQ | Aardvark Therapeutics, Inc. Common Stock | $5.86 | -7.42% | 122K | $138.31M |
| CRDL | NASDAQ | Cardiol Therapeutics Inc. | $1.19 | -3.25% | 680K | $136.02M |
| CNTB | NASDAQ | Connect Biopharma Holdings Limited | $2.14 | -2.73% | 328K | $134.74M |
| CDXS | NASDAQ | Codexis, Inc. | $1.48 | -25.63% | 10.4M | $134.53M |
| HURA | NASDAQ | TuHURA Biosciences, Inc. | $2.11 | -1.86% | 204K | $134.37M |
| NGEN | NASDAQ | NervGen Pharma Corp. Common stock | $1.69 | -2.87% | 569K | $133.97M |
| PEPG | NASDAQ | PepGen Inc. | $1.93 | -8.10% | 734K | $133.5M |
| VOR | NASDAQ | Vor Biopharma Inc. | $19.26 | +1.48% | 639K | $132.01M |
| OGI | NASDAQ | Organigram Global Inc. | $0.90 | +3.29% | 198K | $131.58M |
| GNLX | NASDAQ | Genelux Corporation | $2.89 | -2.36% | 154K | $129.59M |
| ANIX | NASDAQ | Anixa Biosciences, Inc. | $3.40 | +2.41% | 339K | $125.89M |
| CVRX | NASDAQ | CVRx, Inc. | $5.43 | +4.42% | 197K | $125.78M |
| IFRX | NASDAQ | InflaRx N.V. | $1.74 | +0.58% | 823K | $125.69M |
| ACOG | NASDAQ | Alpha Cognition Inc | $7.90 | -4.01% | 29K | $122.7M |
| ADAG | NASDAQ | Adagene Inc. | $3.20 | -5.04% | 127K | $120.48M |
| STIM | NASDAQ | Neuronetics, Inc. | $1.76 | +6.02% | 1.1M | $120.39M |
| JYNT | NASDAQ | The Joint Corp. | $8.35 | -0.12% | 20K | $119.03M |
| OPRX | NASDAQ | OptimizeRx Corp. | $6.69 | +0.60% | 195K | $117.09M |
| MXCT | NASDAQ | MaxCyte, Inc. | $1.08 | -3.57% | 505K | $115.69M |
| RCEL | NASDAQ | Avita Medical Inc. | $4.61 | 0.00% | 82K | $114.53M |
| XGN | NASDAQ | Exagen Inc. | $4.39 | +3.29% | 187K | $113.07M |
| FBIO | NASDAQ | Fortress Biotech, Inc. | $3.34 | -2.62% | 414K | $110.95M |
| VANI | NASDAQ | Vivani Medical, Inc. | $1.28 | -7.91% | 203K | $110.38M |
| SEER | NASDAQ | Seer, Inc. | $2.17 | -1.36% | 522K | $108.31M |
| KRRO | NASDAQ | Korro Bio, Inc. | $11.50 | -6.12% | 147K | $105.9M |
| HUMA | NASDAQ | Humacyte, Inc. | $0.62 | -2.16% | 2.5M | $104.97M |
| PBLS | NASDAQ | Parabilis Medicines, Inc. | $29.60 | -1.04% | 350K | $102.44M |
| PLYX | NASDAQ | Polaryx Therapeutics, Inc. Common Stock | $2.05 | -2.84% | 90K | $102.18M |
| ENTX | NASDAQ | Entera Bio Ltd. | $2.03 | +3.57% | 163K | $101.04M |